ARMC
ELV icon

American Research & Management Company’s Elevance Health ELV Stock Holding History

American Research & Management Company’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15
Closed -$5K – 379
2021
Q1 		$5K Sell
15
-6
-29% -$1.93K ﹤0.01% 328
2020
Q4 		$7K Hold
21
– – ﹤0.01% 309
2020
Q3 		$6K Buy
21
+15
+250% +$4.04K ﹤0.01% 283
2020
Q2 		$2K Buy
+6
New +$1.6K ﹤0.01% 325

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

American Research & Management Company's ELV Position: Q2 2021 in Review

American Research & Management Company sold out of Elevance Health (ELV) in Q2 2021, closing a stake of 15 shares — an estimated $5K sold.

American Research & Management Company first reported a position in ELV in Q2 2020 and held it in 4 quarters. The position peaked at $7K in Q4 2020. 1,234 funds tracked by Wall St. Rank hold ELV as of Q2 2021.

  • American Research & Management Company reported no remaining Elevance Health position as of Q2 2021 after selling out during the quarter.
  • American Research & Management Company sold 15 Elevance Health shares in Q2 2021, an estimated $5K.
  • American Research & Management Company first reported a position in Elevance Health in Q2 2020 and held it in 4 quarters.
  • American Research & Management Company's Elevance Health position peaked at $7K in Q4 2020.
  • 1,234 funds tracked by Wall St. Rank held Elevance Health as of Q2 2021.

Based on American Research & Management Company's 13F filing for Q2 2021, filed 16 Jul 2021.